Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × iron isomaltoside 1000 × Clear all

NCT05913414 2023-06-22

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Phase 2 Recruiting

Classical hematologyHead & Neck

Nasopharyngeal Carcinoma, Anemia, Anemia, Iron-Deficiency